10:34 AM EST, 01/07/2025 (MT Newswires) -- Actuate Therapeutics ( ACTU ) said Tuesday that the European Medicines Agency has granted orphan medicinal product designation to elraglusib for the treatment of pancreatic ductal adenocarcinoma. The company said the designation is granted to therapies intended for the treatment of life-threatening diseases that affect no more than two in 10,000 people in...

10:30 AM EST, 01/07/2025 (MT Newswires) -- NEO Battery Materials ( NBMFF ) on Tuesday announced the launch of an advanced high-performance silicon anode product with breakthrough battery capacity. The NBMSiDE P-300 product line showed a 43% to 130% improvement in initial battery capacity over traditional graphite anodes with less material used, the company said. NEO, which has submitted a...

10:35 AM EST, 01/07/2025 (MT Newswires) -- (Updates throughout with JPMorgan's ( JPM ) comments.) JPMorgan ( JPM ) is leaving climate group Net-Zero Banking Alliance, a company spokesperson told MT Newswires Tuesday. We will continue to work independently to advance the interests of our firm, our shareholders and our clients and remain focused on pragmatic solutions to help further...

10:34 AM EST, 01/07/2025 (MT Newswires) -- Rezolute ( RZLT ) said Tuesday it has received the US Food and Drug Administration's Breakthrough Therapy designation for its ersodetug monoclonal antibody to treat hypoglycemia due to congenital hyperinsulinism. The regulator's decision was based on the company's phase 2b trial of ersodetug in patients with congenital hyperinsulinism, which safely showed significant improvements...